Overview
Mild cognitive impairment (MCI) and dementia both involve cognitive decline, but differ in severity and impact on daily life. MCI causes noticeable but manageable memory and thinking issues, while dementia leads to substantial impairments that interfere with independence. MCI can remain stable or worsen, whereas dementia typically progresses over time.
Disease Summaries
Mild Cognitive Impairment (MCI): Mild cognitive impairment (MCI) is also known as mild or "pre-dementia" in which patients experience forgetfulness or other cognitive problems (such as issues with language or thinking) that do not prevent them from daily functioning. A small proportion of patients have MCI due to depression, medication side effects, sleep disturbances such as sleep apnea, low vitamin B12 levels or low thyroid function. Some controllable risk factors include excessive alcohol intake, high blood pressure, lack of exercise, as well as lack of mental stimulation. Patients with MCI have a high risk for developing dementia, which occurs in about 14% of cases.
Dementia: Dementia is a general term for a decline in memory, thinking, or other cognitive abilities that interferes with daily life. It is not a normal part of aging. Dementia can be caused by a variety of conditions, the most common being Alzheimer's disease. Other causes include vascular dementia (due to strokes or blood flow issues), Lewy body dementia, and frontotemporal dementia. Symptoms may include memory loss, confusion, language difficulties, personality changes, and impaired judgment. Risk factors include advanced age, family history, cardiovascular disease, diabetes, and head injury.
Comparing Symptoms
Overlapping Symptoms
- Memory lapses
- Difficulty with concentration
- Trouble finding words
- Challenges with planning or decision-making
- Increased forgetfulness compared to baseline
Mild Cognitive Impairment (MCI) Specific Symptoms
- Noticeable memory or thinking issues, but not severe
- Preserved ability to perform daily activities
- Often aware of cognitive changes
- May remain stable or progress slowly
- Higher risk of developing dementia
Dementia Specific Symptoms
- Significant memory loss and confusion
- Impaired judgment and reasoning
- Difficulty with daily activities and self-care
- Personality or behavior changes
- Progressive and typically irreversible
Treatment Approaches
Mild Cognitive Impairment (MCI) Treatment Approaches
There are no medications to cure MCI. Lifestyle measures such as regular exercise may be helpful. A doctor can also review medications that can worsen MCI symptoms, evaluate for sleep problems, evaluate for depression, or perform bloodwork to rule out low thyroid function or B12 levels.
Dementia Treatment Approaches
There is no cure for most types of dementia. However, treatment focuses on managing symptoms and improving quality of life. Certain medications such as cholinesterase inhibitors (e.g., donepezil) or memantine may help with memory or behavior in some patients. Non-drug approaches such as maintaining a structured routine, engaging in physical and mental activity, ensuring proper nutrition, and providing caregiver support are also important. Treatable contributing factors like sleep disturbances, depression, or medication side effects should be evaluated by a physician.
Reviewed By:

Kenji Taylor, MD, MSc (Family Medicine, Primary Care)
Dr. Taylor is a Japanese-African American physician who grew up and was educated in the United States but spent a considerable amount of time in Japan as a college student, working professional and now father of three. After graduating from Brown, he worked in finance first before attending medical school at Penn. He then completed a fellowship with the Centers for Disease Control before going on to specialize in Family and Community Medicine at the University of California, San Francisco (UCSF) where he was also a chief resident. After a faculty position at Stanford, he moved with his family to Japan where he continues to see families on a military base outside of Tokyo, teach Japanese residents and serve remotely as a medical director for Roots Community Health Center. He also enjoys editing and writing podcast summaries for Hippo Education.

Shohei Harase, MD (Neurology)
Dr. Harase spent his junior and senior high school years in Finland and the U.S. After graduating from the University of Washington (Bachelor of Science, Molecular and Cellular Biology), he worked for Apple Japan Inc. before entering the University of the Ryukyus School of Medicine. He completed his residency at Okinawa Prefectural Chubu Hospital, where he received the Best Resident Award in 2016 and 2017. In 2021, he joined the Department of Cerebrovascular Medicine at the National Cerebral and Cardiovascular Center, specializing in hyperacute stroke.
Content updated on Apr 27, 2025
Following the Medical Content Editorial Policy
Was this page helpful?
Tell your friends about us.
We would love to help them too.
Still not sure if you need
to see a doctor?
Try a symptom check testHow Ubie Can Help You
With a free 3-min quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms

Our AI

Your report

Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
Ubie is supervised by 50+ medical experts worldwide
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.






Ubie is recognized by healthcare and tech leaders

“World’s Best Digital
Health Companies”
Newsweek 2024

“Best With AI”
Google Play Best of 2023

“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1References
Mariani E, Monastero R, Mecocci P (2007). Mild cognitive impairment: a systematic review. Journal of Alzheimer's disease: JAD.
https://pubmed.ncbi.nlm.nih.gov/17851192/Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015 Oct 24;386(10004):1672-82. doi: 10.1016/S0140-6736(15)00461-4. PMID: 26595641; PMCID: PMC5970949.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00461-4/fulltextYounes K, Miller BL. Frontotemporal Dementia: Neuropathology, Genetics, Neuroimaging, and Treatments. Psychiatr Clin North Am. 2020 Jun;43(2):331-344. doi: 10.1016/j.psc.2020.02.006. Epub 2020 Apr 8. PMID: 32439025.
https://www.sciencedirect.com/science/article/abs/pii/S0193953X2030006X?via%3Dihub